PETRI DISH PERSPECTIVES: BIOTECH UNLEASHED

About PETRI DISH PERSPECTIVES: BIOTECH UNLEASHED

Burma | Chicago Scientist 🥼🧪🔬 Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎 Stream new episodes every THURSDAY! https://linktr.ee/maneadkhin #biotech #pharma #healthcare #podcast #petridishperspectives

Publisher

Manead Khin

Category

health & fitness · science · science

Language

en

Explicit

No

First episode

12 Mar 2025

Latest episode

8 Oct 2026

Latest episodes

2 of 87 episodes have a transcript.

1. 

   8 Oct 2026

   Episode 76: Dr. Avinash Jayaraman on Why Your Kid's Screen Time Is a Clinical Emergency

   Send us Fan Mail After training as a physician, earning an MBA from Wharton, and co-founding Sonara Health, a digital health company that raised over $10 million from the NIH, VCs, Dr. Avinash Jayaraman could have gone in almost any direction. He chose to focus on one of the most urgent and underserved crises in adolescent health: the mental health epidemic driven by technology overuse. In this episode, Dr. Jayaraman unpacks why screen time and social media have become a clinical problem, not...

2. 

   1 Oct 2026

   September 2026: Biotech & Pharma NEWS Roundup

   Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for September 2026! This month was defined by blockbuster dealmaking, historic FDA approvals, and a growing recognition that pharmaceutical innovation is shifting east. AstraZeneca made a $2 billion strategic bet on Summit Therapeutics and its ivonescimab program, Novo Nordisk paid up to $2.6 billion for a once-weekly oral GLP-1 from China's Hengrui, and Eli Lilly continued its relentless de...

3. 

   1 Oct 2026

   Episode 75: Hengrui

   Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Jiangsu Hengrui Pharmaceuticals, the Chinese pharma giant that started as a state-owned generic drug factory in 1970 and quietly became one of the most important drug companies in the world. Over $15 billion in deals with GSK and Novo Nordisk. The world's top clinical trial sponsor. One of the top five drug pipelines globally. All from a city most people can't find on a map. We break down how Hengrui made the pivot from g...

Inside a recent episode

Episode 61: Danaher

Published 25 Jun 2026 · Transcript excerpt

[…] While biotech headlines are very fancy and innovative and so impressive, we just ignore, tend to ignore the infrastructure that supply the whole chain, right? So again, companies supplying the underlying infrastructure frequently generate more consistent and predictable returns and revenue just because regardless of a company that succeeds or fails, you're still going to make your money. And second, systems outperform heroes. Danaher's success did not depend on a single scientist or a person or a breakthrough tech, and it depended on repeatable operating framework. And third, operational excellence does compound. […]

Who has been a guest on PETRI DISH PERSPECTIVES: BIOTECH UNLEASHED

Names identified in recent episode analyses. Showing up to five guests.

• Dr John Murphy
• Elliot Justin
• Dem

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Spotify

5.0 / 5

2 ratings

Podcast Authority Score: 41 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

69

Social presence

0

YouTube

0

Engagement

32

Contact PETRI DISH PERSPECTIVES: BIOTECH UNLEASHED

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Shows with a similar audience

• 

  Invest in Progress

• 

  Invest Like the Best with Patrick O'Shaughnessy

• 

  Dwarkesh Podcast

• 

  The Ezra Klein Show

Questions about PETRI DISH PERSPECTIVES: BIOTECH UNLEASHED